In a move that sent its stock higher, Quest Diagnostics reported Q1 2026 results that not only beat analyst expectations but prompted an upward revision of its full-year outlook. With revenues hitting ...

Quest Diagnostics is launching a chatbot tailored for laboratory test results as it seeks to allow patients the ability to get a handle on their findings and perform deeper dives on their own health.

If you’ve recently visited Quest Diagnostics, you’re likely waiting for results and wondering about the bill that might follow. While the company is hitting new financial highs in 2026, the patient ...

Quest Diagnostics announced it is teaming up with Google Cloud to develop artificial intelligence programs that can personally respond to patients, providers and other customers. That includes ...

Quest Diagnostics is working with Google Cloud to enhance its data management and customer experience using generative AI technology. In a March 18 press release, the Secaucus-based clinical testing ...

Healthcare diagnostics company Quest Diagnostics (NYSE:DGX) reported Q1 CY2026 results topping the market’s revenue expectations, with sales up 9.2% year on year to $2.90 billion. The company’s ...

DGX posts Q1 2026 earnings and revenue beat, with adjusted EPS up 13% and shares rising in pre-market trading.

Quest Diagnostics Incorporated announced its Q3 earnings yesterday - revenues year-to-date are $8.23bn, and net income $845m. DGX is finally demonstrating a strong post-pandemic recovery, with Q3 ...

Quest Diagnostics may be the preferred lab your health insurance, doctors, or specialists use for blood work or other samples. We’re reviewing its sub-brand Quest Health, from which you can order your ...

Corewell Health has signed on to a joint venture with Quest Diagnostics covering inpatient and outpatient lab management and the construction of a new 100,000-square-foot advanced lab facility. The ...

Detailed price information for Quest Diagnostics Inc (DGX-N) from The Globe and Mail including charting and trades.

Quest Diagnostics (NYSE:DGX) announced a US$500 million senior notes offering. The company also entered a multi year clinical partnership with City of Hope focused on advanced ctDNA testing. The ...